Last reviewed · How we verify

Hippuran I125 — Competitive Intelligence Brief

Hippuran I125 (iodohippurate sodium I125) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: iodohippurate sodium I125. Area: Nephrology.

unknown iodohippurate sodium I125 Nephrology Live · refreshed every 30 min

Target snapshot

Hippuran I125 (iodohippurate sodium I125). Hippuran I125 works by binding to and being excreted by the kidneys, allowing for imaging of renal function.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Hippuran I125 TARGET iodohippurate sodium I125 unknown iodohippurate sodium I125

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (iodohippurate sodium I125 class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Hippuran I125 — Competitive Intelligence Brief. https://druglandscape.com/ci/iodohippurate-sodium-i125. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing